ID   PYGM_HUMAN              Reviewed;         842 AA.
AC   P11217; A0AVK1; A6NDY6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 6.
DT   15-MAR-2017, entry version 202.
DE   RecName: Full=Glycogen phosphorylase, muscle form;
DE            EC=2.4.1.1;
DE   AltName: Full=Myophosphorylase;
GN   Name=PYGM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3447177; DOI=10.1002/prot.340020303;
RA   Burke J., Hwang P.K., Anderson L., Lebo R., Gorin F., Fletterick R.J.;
RT   "Intron/exon structure of the human gene for the muscle isozyme of
RT   glycogen phosphorylase.";
RL   Proteins 2:177-187(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9633816;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#;
RA   Kubisch C., Wicklein E.M., Jentsch T.J.;
RT   "Molecular diagnosis of McArdle disease: revised genomic structure of
RT   the myophosphorylase gene and identification of a novel mutation.";
RL   Hum. Mutat. 12:27-32(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RA   Carty M.D., Clancy Y.C., Soeller W.C.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 676-842 (ISOFORM 1).
RX   PubMed=3840433; DOI=10.1111/j.1432-1033.1985.tb09193.x;
RA   Hwang P.K., See Y.P., Vincentini A.M., Powers M.A., Fletterick R.J.,
RA   Crerar M.M.;
RT   "Comparative sequence analysis of rat, rabbit, and human muscle
RT   glycogen phosphorylase cDNAs.";
RL   Eur. J. Biochem. 152:267-274(1985).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 455-676 (ISOFORM 1).
RX   PubMed=3466902; DOI=10.1172/JCI112794;
RA   Gautron S., Daegelen D., Mennecier F., Dubocq D., Kahn A.,
RA   Dreyfus J.-C.;
RT   "Molecular mechanisms of McArdle's disease (muscle glycogen
RT   phosphorylase deficiency). RNA and DNA analysis.";
RL   J. Clin. Invest. 79:275-281(1987).
RN   [10]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=1150650;
RA   Carty T.J., Tu J., Graves D.J.;
RT   "Regulation of glycogen phosphorylase. Role of the peptide region
RT   surrounding the phosphoserine residue in determining enzyme
RT   properties.";
RL   J. Biol. Chem. 250:4980-4985(1975).
RN   [11]
RP   VARIANTS GSD5 SER-205 AND THR-543.
RX   PubMed=8316268; DOI=10.1056/NEJM199307223290404;
RA   Tsujino S., Shanske S., Dimauro S.;
RT   "Molecular genetic heterogeneity of myophosphorylase deficiency
RT   (McArdle's disease).";
RL   N. Engl. J. Med. 329:241-245(1993).
RN   [12]
RP   VARIANTS GSD5 PRO-397 AND LYS-655.
RX   PubMed=8535454; DOI=10.1002/humu.1380060318;
RA   Tsujino S., Shanske S., Martinuzzi A., Heiman-Patterson T.,
RA   Dimauro S.;
RT   "Two novel missense mutations (E654K, L396P) in Caucasian patients
RT   with myophosphorylase deficiency (McArdle's disease).";
RL   Hum. Mutat. 6:276-277(1995).
RN   [13]
RP   VARIANTS GSD5 SER-205; PRO-292; PRO-397; THR-543; LYS-655 AND PHE-709
RP   DEL.
RX   PubMed=7603523; DOI=10.1002/mus.880181407;
RA   Tsujino S., Shanske S., Nonaka I., DiMauro S.;
RT   "The molecular genetic basis of myophosphorylase deficiency (McArdle's
RT   disease).";
RL   Muscle Nerve 3:S23-S27(1995).
RN   [14]
RP   VARIANTS GSD5 GLU-666 AND ARG-686.
RX   PubMed=9506549; DOI=10.1002/ana.410430310;
RA   Vorgerd M., Kubisch C., Burwinkel B., Reichmann H., Mortier W.,
RA   Tettenborn B., Pongratz D., Lindemuth R., Tegenthoff M., Malin J.P.,
RA   Kilimann M.W.;
RT   "Mutation analysis in myophosphorylase deficiency (McArdle's
RT   disease).";
RL   Ann. Neurol. 43:326-331(1998).
RN   [15]
RP   VARIANT GSD5 PRO-116.
RX   PubMed=10417800;
RX   DOI=10.1002/(SICI)1097-4598(199908)22:8<1136::AID-MUS21>3.0.CO;2-2;
RA   Gamez J., Fernandez R., Bruno C., Andreu A.L., Cervera C., Navarro C.,
RA   Schwartz S., Dimauro S.;
RT   "A new mutation in the regulatory domain of the myophosphorylase gene
RT   affecting protein dimer contact.";
RL   Muscle Nerve 22:1136-1138(1999).
RN   [16]
RP   VARIANTS GSD5 SER-205 AND TYR-685.
RX   PubMed=10382911; DOI=10.1016/S0960-8966(98)00125-4;
RA   Andreu A.L., Bruno C., Tamburino L., Gamez J., Shanske S., Cervera C.,
RA   Navarro C., DiMauro S.;
RT   "A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish
RT   patient with McArdle's disease.";
RL   Neuromuscul. Disord. 9:171-173(1999).
RN   [17]
RP   VARIANT GSD5 SER-205.
RX   PubMed=10382912; DOI=10.1016/S0960-8966(98)00127-8;
RA   Rubio J.C., Martin M.A., Garcia A., Campos Y., Cabello A.,
RA   Culebras J.M., Arenas J.;
RT   "McArdle's disease associated with homozygosity for the missense
RT   mutation Gly204Ser of the myophosphorylase gene in a Spanish
RT   patient.";
RL   Neuromuscul. Disord. 9:174-175(1999).
RN   [18]
RP   VARIANT GSD5 ARG-798.
RX   PubMed=10681080; DOI=10.1001/archneur.57.2.217;
RA   Fernandez R., Navarro C., Andreu A.L., Bruno C., Shanske S., Gamez J.,
RA   Teijeira S., Hernandez I., Teijeiro A., Fernandez J.M., Musumeci O.,
RA   DiMauro S.;
RT   "A novel missense mutation (W797R) in the myophosphorylase gene in
RT   Spanish patients with McArdle disease.";
RL   Arch. Neurol. 57:217-219(2000).
RN   [19]
RP   VARIANT GSD5 ARG-798.
RX   PubMed=10590419;
RX   DOI=10.1002/(SICI)1097-4598(200001)23:1<129::AID-MUS20>3.0.CO;2-F;
RA   Rubio J.C., Martin M.A., Campos Y., Auciello R., Cabello A.,
RA   Arenas J.;
RT   "A missense mutation W797R in the myophosphorylase gene in a Spanish
RT   patient with McArdle's disease.";
RL   Muscle Nerve 23:129-131(2000).
RN   [20]
RP   VARIANT GSD5 ASN-488.
RX   PubMed=10714589; DOI=10.1016/S0960-8966(99)00082-6;
RA   Rubio J.C., Martin M.A., Campos Y., Cabello A., Arenas J.;
RT   "A missense mutation T487N in the myophosphorylase gene in a Spanish
RT   patient with McArdle's disease.";
RL   Neuromuscul. Disord. 10:138-140(2000).
RN   [21]
RP   VARIANT GSD5 ASP-660.
RX   PubMed=10899452; DOI=10.1016/S0960-8966(99)00124-8;
RA   Martin M.A., Rubio J.C., Campos Y., Ricoy J.R., Cabello A., Arenas J.;
RT   "A homozygous missense mutation (A659D) in the myophosphorylase gene
RT   in a Spanish patient with McArdle's disease.";
RL   Neuromuscul. Disord. 10:447-449(2000).
RN   [22]
RP   VARIANTS GSD5 PRO-116; TRP-194; SER-205; LYS-349; ASN-488; TRP-602;
RP   ASP-660; TYR-685; VAL-704 AND ARG-798.
RX   PubMed=11706962; DOI=10.1002/ana.1225.abs;
RA   Martin M.A., Rubio J.C., Buchbinder J., Fernandez-Hojas R.,
RA   del Hoyo P., Teijeira S., Gamez J., Navarro C., Fernandez J.M.,
RA   Cabello A., Campos Y., Cervera C., Culebras J.M., Andreu A.L.,
RA   Fletterick R.J., Arenas J.;
RT   "Molecular heterogeneity of myophosphorylase deficiency (McArdle's
RT   disease): a genotype-phenotype correlation study.";
RL   Ann. Neurol. 50:574-581(2001).
RN   [23]
RP   VARIANT GSD5 PRO-687.
RX   PubMed=12031624; DOI=10.1016/S0960-8966(01)00320-0;
RA   Bruno C., Lanzillo R., Biedi C., Iadicicco L., Minetti C., Santoro L.;
RT   "Two new mutations in the myophosphorylase gene in Italian patients
RT   with McArdle's disease.";
RL   Neuromuscul. Disord. 12:498-500(2002).
CC   -!- FUNCTION: Phosphorylase is an important allosteric enzyme in
CC       carbohydrate metabolism. Enzymes from different sources differ in
CC       their regulatory mechanisms and in their natural substrates.
CC       However, all known phosphorylases share catalytic and structural
CC       properties.
CC   -!- CATALYTIC ACTIVITY: ((1->4)-alpha-D-glucosyl)(n) + phosphate =
CC       ((1->4)-alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- ENZYME REGULATION: Activity of phosphorylase is controlled both by
CC       allosteric means (through the noncovalent binding of metabolites)
CC       and by covalent modification. Thus AMP allosterically activates,
CC       whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit,
CC       phosphorylase B.
CC   -!- SUBUNIT: Homodimer. Dimers associate into a tetramer to form the
CC       enzymatically active phosphorylase A.
CC   -!- INTERACTION:
CC       O43741:PRKAB2; NbExp=5; IntAct=EBI-357469, EBI-1053424;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-357469, EBI-741158;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11217-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11217-2; Sequence=VSP_043047;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylation of Ser-15 converts phosphorylase B
CC       (unphosphorylated) to phosphorylase A.
CC       {ECO:0000269|PubMed:1150650}.
CC   -!- DISEASE: Glycogen storage disease 5 (GSD5) [MIM:232600]: A
CC       metabolic disorder resulting in myopathy characterized by exercise
CC       intolerance, cramps, muscle weakness and recurrent myoglobinuria.
CC       {ECO:0000269|PubMed:10382911, ECO:0000269|PubMed:10382912,
CC       ECO:0000269|PubMed:10417800, ECO:0000269|PubMed:10590419,
CC       ECO:0000269|PubMed:10681080, ECO:0000269|PubMed:10714589,
CC       ECO:0000269|PubMed:10899452, ECO:0000269|PubMed:11706962,
CC       ECO:0000269|PubMed:12031624, ECO:0000269|PubMed:7603523,
CC       ECO:0000269|PubMed:8316268, ECO:0000269|PubMed:8535454,
CC       ECO:0000269|PubMed:9506549}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycogen phosphorylase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32598; AAA60231.1; -; Genomic_DNA.
DR   EMBL; M32579; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32580; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32581; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32582; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32583; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32584; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32585; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32586; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32587; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32588; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32589; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32590; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32591; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32592; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32593; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32594; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32595; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32596; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32597; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; U94777; AAC52081.1; -; Genomic_DNA.
DR   EMBL; U94774; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; U94775; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; U94776; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; AF066859; AAC17451.1; -; mRNA.
DR   EMBL; AK056607; BAG51762.1; -; mRNA.
DR   EMBL; AP001462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74284.1; -; Genomic_DNA.
DR   EMBL; BC126392; AAI26393.1; -; mRNA.
DR   EMBL; BC130514; AAI30515.1; -; mRNA.
DR   EMBL; X03031; CAA26834.1; -; mRNA.
DR   EMBL; M16013; AAA36216.1; -; mRNA.
DR   CCDS; CCDS53659.1; -. [P11217-2]
DR   CCDS; CCDS8079.1; -. [P11217-1]
DR   PIR; A27335; A27335.
DR   RefSeq; NP_001158188.1; NM_001164716.1. [P11217-2]
DR   RefSeq; NP_005600.1; NM_005609.3. [P11217-1]
DR   UniGene; Hs.154084; -.
DR   PDB; 1Z8D; X-ray; 2.30 A; A=1-842.
DR   PDBsum; 1Z8D; -.
DR   ProteinModelPortal; P11217; -.
DR   SMR; P11217; -.
DR   BioGrid; 111795; 12.
DR   IntAct; P11217; 25.
DR   MINT; MINT-1134630; -.
DR   STRING; 9606.ENSP00000164139; -.
DR   BindingDB; P11217; -.
DR   ChEMBL; CHEMBL3526; -.
DR   DrugBank; DB04544; 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide.
DR   DrugBank; DB04013; 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide.
DR   DrugBank; DB03657; 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose.
DR   DrugBank; DB02320; 1-N-Acetyl-Beta-D-Glucosamine.
DR   DrugBank; DB02604; 2-Deoxy-Glucose-6-Phosphate.
DR   DrugBank; DB04044; 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid.
DR   DrugBank; DB03383; 5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide.
DR   DrugBank; DB02720; Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide.
DR   DrugBank; DB02007; alpha-D-glucose 6-phosphate.
DR   DrugBank; DB02843; Alpha-D-Glucose-1-Phosphate.
DR   DrugBank; DB01823; Beta-D-Glucopyranose Spirohydantoin.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   DrugBank; DB03286; C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide.
DR   DrugBank; DB02719; C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide.
DR   DrugBank; DB03496; Flavopiridol.
DR   DrugBank; DB02348; Fluoro-Phosphite Ion.
DR   DrugBank; DB04195; Heptulose-2-Phosphate.
DR   DrugBank; DB02519; Indirubin-5-Sulphonate.
DR   DrugBank; DB04566; Inosinic Acid.
DR   DrugBank; DB04083; N'-Pyridoxyl-Lysine-5'-Monophosphate.
DR   DrugBank; DB03218; N-Acetyl-N'-Beta-D-Glucopyranosyl Urea.
DR   DrugBank; DB04295; N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea.
DR   DrugBank; DB02471; Nojirimycine Tetrazole.
DR   DrugBank; DB04522; Phosphonoserine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   CAZy; GT35; Glycosyltransferase Family 35.
DR   iPTMnet; P11217; -.
DR   PhosphoSitePlus; P11217; -.
DR   BioMuta; PYGM; -.
DR   DMDM; 3041717; -.
DR   EPD; P11217; -.
DR   MaxQB; P11217; -.
DR   PaxDb; P11217; -.
DR   PeptideAtlas; P11217; -.
DR   PRIDE; P11217; -.
DR   DNASU; 5837; -.
DR   Ensembl; ENST00000164139; ENSP00000164139; ENSG00000068976. [P11217-1]
DR   Ensembl; ENST00000377432; ENSP00000366650; ENSG00000068976. [P11217-2]
DR   GeneID; 5837; -.
DR   KEGG; hsa:5837; -.
DR   UCSC; uc001oax.5; human. [P11217-1]
DR   CTD; 5837; -.
DR   DisGeNET; 5837; -.
DR   GeneCards; PYGM; -.
DR   GeneReviews; PYGM; -.
DR   HGNC; HGNC:9726; PYGM.
DR   HPA; HPA056003; -.
DR   MalaCards; PYGM; -.
DR   MIM; 232600; phenotype.
DR   MIM; 608455; gene.
DR   neXtProt; NX_P11217; -.
DR   OpenTargets; ENSG00000068976; -.
DR   Orphanet; 368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency.
DR   PharmGKB; PA34069; -.
DR   eggNOG; KOG2099; Eukaryota.
DR   eggNOG; COG0058; LUCA.
DR   GeneTree; ENSGT00390000016886; -.
DR   HOGENOM; HOG000278444; -.
DR   HOVERGEN; HBG006848; -.
DR   InParanoid; P11217; -.
DR   KO; K00688; -.
DR   OMA; RSCAYTN; -.
DR   OrthoDB; EOG091G03RB; -.
DR   PhylomeDB; P11217; -.
DR   TreeFam; TF300309; -.
DR   BioCyc; MetaCyc:HS00949-MONOMER; -.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   EvolutionaryTrace; P11217; -.
DR   GenomeRNAi; 5837; -.
DR   PRO; PR:P11217; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000068976; -.
DR   CleanEx; HS_PYGM; -.
DR   Genevisible; P11217; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0008184; F:glycogen phosphorylase activity; IBA:GO_Central.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0005980; P:glycogen catabolic process; IBA:GO_Central.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   CDD; cd04300; GT1_Glycogen_Phosphorylase; 1.
DR   InterPro; IPR011833; Glycg_phsphrylas.
DR   InterPro; IPR000811; Glyco_trans_35.
DR   PANTHER; PTHR11468; PTHR11468; 1.
DR   Pfam; PF00343; Phosphorylase; 1.
DR   PIRSF; PIRSF000460; Pprylas_GlgP; 1.
DR   TIGRFAMs; TIGR02093; P_ylase; 1.
DR   PROSITE; PS00102; PHOSPHORYLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   Carbohydrate metabolism; Complete proteome; Disease mutation;
KW   Glycogen metabolism; Glycogen storage disease; Glycosyltransferase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P00489}.
FT   CHAIN         2    842       Glycogen phosphorylase, muscle form.
FT                                /FTId=PRO_0000188529.
FT   BINDING      76     76       AMP. {ECO:0000250}.
FT   SITE        109    109       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        143    143       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        156    156       May be involved in allosteric control.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P00489}.
FT   MOD_RES      15     15       Phosphoserine; by PHK; in form
FT                                phosphorylase A.
FT                                {ECO:0000269|PubMed:1150650}.
FT   MOD_RES     204    204       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     227    227       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     364    364       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9ET01}.
FT   MOD_RES     430    430       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WUB3}.
FT   MOD_RES     473    473       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9WUB3}.
FT   MOD_RES     514    514       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ET01}.
FT   MOD_RES     681    681       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   MOD_RES     747    747       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     748    748       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   VAR_SEQ      82    169       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043047.
FT   VARIANT     116    116       L -> P (in GSD5; dbSNP:rs776680924).
FT                                {ECO:0000269|PubMed:10417800,
FT                                ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014002.
FT   VARIANT     194    194       R -> W (in GSD5; dbSNP:rs376581557).
FT                                {ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014003.
FT   VARIANT     205    205       G -> S (in GSD5; dbSNP:rs119103251).
FT                                {ECO:0000269|PubMed:10382911,
FT                                ECO:0000269|PubMed:10382912,
FT                                ECO:0000269|PubMed:11706962,
FT                                ECO:0000269|PubMed:7603523,
FT                                ECO:0000269|PubMed:8316268}.
FT                                /FTId=VAR_003431.
FT   VARIANT     292    292       L -> P (in GSD5; rare mutation;
FT                                dbSNP:rs780375860).
FT                                {ECO:0000269|PubMed:7603523}.
FT                                /FTId=VAR_014004.
FT   VARIANT     349    349       E -> K (in GSD5).
FT                                {ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014005.
FT   VARIANT     397    397       L -> P (in GSD5).
FT                                {ECO:0000269|PubMed:7603523,
FT                                ECO:0000269|PubMed:8535454}.
FT                                /FTId=VAR_003432.
FT   VARIANT     414    414       R -> G (in dbSNP:rs11231866).
FT                                /FTId=VAR_061198.
FT   VARIANT     488    488       T -> N (in GSD5).
FT                                {ECO:0000269|PubMed:10714589,
FT                                ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014006.
FT   VARIANT     543    543       K -> T (in GSD5; dbSNP:rs119103252).
FT                                {ECO:0000269|PubMed:7603523,
FT                                ECO:0000269|PubMed:8316268}.
FT                                /FTId=VAR_003433.
FT   VARIANT     602    602       R -> W (in GSD5; dbSNP:rs750195683).
FT                                {ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014007.
FT   VARIANT     655    655       E -> K (in GSD5; dbSNP:rs119103253).
FT                                {ECO:0000269|PubMed:7603523,
FT                                ECO:0000269|PubMed:8535454}.
FT                                /FTId=VAR_003434.
FT   VARIANT     660    660       A -> D (in GSD5).
FT                                {ECO:0000269|PubMed:10899452,
FT                                ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014008.
FT   VARIANT     666    666       Q -> E (in GSD5; dbSNP:rs119103256).
FT                                {ECO:0000269|PubMed:9506549}.
FT                                /FTId=VAR_014009.
FT   VARIANT     685    685       N -> Y (in GSD5).
FT                                {ECO:0000269|PubMed:10382911,
FT                                ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014010.
FT   VARIANT     686    686       G -> R (in GSD5; dbSNP:rs144081869).
FT                                {ECO:0000269|PubMed:9506549}.
FT                                /FTId=VAR_014011.
FT   VARIANT     687    687       A -> P (in GSD5).
FT                                {ECO:0000269|PubMed:12031624}.
FT                                /FTId=VAR_014012.
FT   VARIANT     704    704       A -> V (in GSD5).
FT                                {ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014013.
FT   VARIANT     709    709       Missing (in GSD5; common in Japanese
FT                                patients). {ECO:0000269|PubMed:7603523}.
FT                                /FTId=VAR_014014.
FT   VARIANT     798    798       W -> R (in GSD5; dbSNP:rs119103258).
FT                                {ECO:0000269|PubMed:10590419,
FT                                ECO:0000269|PubMed:10681080,
FT                                ECO:0000269|PubMed:11706962}.
FT                                /FTId=VAR_014015.
FT   CONFLICT    791    791       L -> W (in Ref. 1; AAA60231).
FT                                {ECO:0000305}.
FT   HELIX         7     10       {ECO:0000244|PDB:1Z8D}.
FT   HELIX        11     13       {ECO:0000244|PDB:1Z8D}.
FT   HELIX        25     38       {ECO:0000244|PDB:1Z8D}.
FT   TURN         44     46       {ECO:0000244|PDB:1Z8D}.
FT   HELIX        49     78       {ECO:0000244|PDB:1Z8D}.
FT   STRAND       82     86       {ECO:0000244|PDB:1Z8D}.
FT   HELIX        96    102       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       106    114       {ECO:0000244|PDB:1Z8D}.
FT   TURN        115    117       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       120    126       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       136    150       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      155    160       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      168    172       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      175    179       {ECO:0000244|PDB:1Z8D}.
FT   TURN        183    186       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       195    197       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      199    204       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      206    210       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      213    218       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      220    232       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      234    236       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      239    248       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       263    270       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       271    277       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       291    313       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       330    333       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      334    341       {ECO:0000244|PDB:1Z8D}.
FT   TURN        342    345       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       346    356       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       362    372       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      373    376       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       382    384       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      387    389       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       390    396       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       398    418       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       423    429       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      431    433       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      435    437       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      439    441       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       442    448       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      451    457       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       458    466       {ECO:0000244|PDB:1Z8D}.
FT   TURN        467    469       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       470    475       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       477    479       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      480    482       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       490    495       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       498    508       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       511    514       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       516    525       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       529    553       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      562    569       {ECO:0000244|PDB:1Z8D}.
FT   TURN        573    576       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       577    593       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      602    607       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       615    631       {ECO:0000244|PDB:1Z8D}.
FT   TURN        635    637       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       638    640       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      641    646       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       651    657       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       658    660       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      662    666       {ECO:0000244|PDB:1Z8D}.
FT   TURN        670    672       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       678    684       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      688    691       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       697    704       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       706    708       {ECO:0000244|PDB:1Z8D}.
FT   STRAND      709    711       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       716    725       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       730    733       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       737    748       {ECO:0000244|PDB:1Z8D}.
FT   TURN        749    751       {ECO:0000244|PDB:1Z8D}.
FT   TURN        756    759       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       760    768       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       774    792       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       795    806       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       810    812       {ECO:0000244|PDB:1Z8D}.
FT   HELIX       814    824       {ECO:0000244|PDB:1Z8D}.
SQ   SEQUENCE   842 AA;  97092 MW;  EBDB7D80D740B68F CRC64;
     MSRPLSDQEK RKQISVRGLA GVENVTELKK NFNRHLHFTL VKDRNVATPR DYYFALAHTV
     RDHLVGRWIR TQQHYYEKDP KRIYYLSLEF YMGRTLQNTM VNLALENACD EATYQLGLDM
     EELEEIEEDA GLGNGGLGRL AACFLDSMAT LGLAAYGYGI RYEFGIFNQK ISGGWQMEEA
     DDWLRYGNPW EKARPEFTLP VHFYGHVEHT SQGAKWVDTQ VVLAMPYDTP VPGYRNNVVN
     TMRLWSAKAP NDFNLKDFNV GGYIQAVLDR NLAENISRVL YPNDNFFEGK ELRLKQEYFV
     VAATLQDIIR RFKSSKFGCR DPVRTNFDAF PDKVAIQLND THPSLAIPEL MRILVDLERM
     DWDKAWDVTV RTCAYTNHTV LPEALERWPV HLLETLLPRH LQIIYEINQR FLNRVAAAFP
     GDVDRLRRMS LVEEGAVKRI NMAHLCIAGS HAVNGVARIH SEILKKTIFK DFYELEPHKF
     QNKTNGITPR RWLVLCNPGL AEVIAERIGE DFISDLDQLR KLLSFVDDEA FIRDVAKVKQ
     ENKLKFAAYL EREYKVHINP NSLFDIQVKR IHEYKRQLLN CLHVITLYNR IKREPNKFFV
     PRTVMIGGKA APGYHMAKMI IRLVTAIGDV VNHDPAVGDR LRVIFLENYR VSLAEKVIPA
     ADLSEQISTA GTEASGTGNM KFMLNGALTI GTMDGANVEM AEEAGEENFF IFGMRVEDVD
     KLDQRGYNAQ EYYDRIPELR QVIEQLSSGF FSPKQPDLFK DIVNMLMHHD RFKVFADYED
     YIKCQEKVSA LYKNPREWTR MVIRNIATSG KFSSDRTIAQ YAREIWGVEP SRQRLPAPDE
     AI
//
